Sugammadex - Merck & Co.
Alternative Names: Bridion; MK-8616; ORG-25969; SCH-900616; Sugammadex; Sugammadex sodium injectionLatest Information Update: 05 Nov 2023
At a glance
- Originator Organon
- Developer Merck & Co
- Class Gamma-Cyclodextrins; Muscle relaxants
- Mechanism of Action Binding agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Neuromuscular blockade